Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.
about
Anthropometric variables accurately predict dual energy x-ray absorptiometric-derived body composition and can be used to screen for diabetesEffects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants.Association of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes.Comparing glucose and hemoglobin A1c diagnostic tests among a high metabolic risk Hispanic population.Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factorsHbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age.Using hemoglobin A1C as a predicting model for time interval from pre-diabetes progressing to diabetes.Effects of age and sex in the diagnosis of type 2 diabetes using glycated haemoglobin in Japan: the Yuport Medical Checkup Centre studySignificance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience.Diabetes mellitus: The epidemic of the century.The prevalence and determinants of undiagnosed and diagnosed type 2 diabetes in middle-aged irish adultsEvaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.Vitamin D insufficiency and abnormal hemoglobin a1c in black and white older personsEvaluation of hemoglobin A1c criteria to assess preoperative diabetes risk in cardiac surgery patientsHbA1c alone is a poor indicator of cardiometabolic risk in middle-aged subjects with pre-diabetes but is suitable for type 2 diabetes diagnosis: a cross-sectional study.The changing relationship between HbA1c and FPG according to different FPG ranges.Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study.Physical function limitations among middle-aged and older adults with prediabetes: one exercise prescription may not fit all.Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults: are two better than one?The metabolic deterioration that antedates diabetes: personal trajectories of HbA(1c) and fasting glucose as early indicators and possible triggers for intervention.The Early Diabetes Intervention Program--is early actually late?Detecting prediabetes among Hispanics/Latinos from diverse heritage groups: Does the test matter? Findings from the Hispanic Community Health Study/Study of Latinos.Fasting glucose and HbA1c levels as risk factors for the development of hypertension in Japanese individuals: Toranomon hospital health management center study 16 (TOPICS 16).Fasting glycemia and glycated hemoglobin categories: Relationship to serum lipoprotein(a) level and disparity in 2 geographic regional groups of Turkey.Accuracy of glycated haemoglobin in screening for pre-diabetes in Asian Indians--a community survey: the Chandigarh Urban Diabetes Study (CUDS).Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009.Low association between fasting and OGTT stimulated glucose levels with HbA1c in overweight children and adolescents.HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction?Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes mellitus.Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects.Assessment of disturbed glucose metabolism and surrogate measures of insulin sensitivity in obese children and adolescents.Diabetic by HbA1c, Normal by OGTT: A Frequent Finding in the Mexico City Diabetes Study.Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.Influence of the glycation gap on the diagnosis of type 2 diabetes.A Single A1C >= 6.5% Accurately Identifies Type 2 Diabetes/Impaired Glucose Tolerance in African Americans.HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.Protocol for the CHORD project (community health outreach to reduce diabetes): a cluster-randomized community health worker trial to prevent diabetes.Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study.
P2860
Q28740744-CF0FD9D0-60CD-4C82-A79F-F25B154E7D98Q30686948-4DAE3EAE-B1D2-4734-9D66-223903E91129Q33607781-B3C5BA15-B7C8-4262-9AEC-8CEF01900FC3Q33627460-348960EE-1E76-4B54-A00B-7FC7A7A12B8FQ33799803-23ACFED1-DD35-40E9-A95E-AC2B7E6D376AQ33865532-563D1198-68CD-4244-879D-E1A3E8D4820CQ33869994-13181B05-3F00-4E6F-A8FF-2203DF6AEC48Q34004933-294A5ABB-33FD-4E47-9BBE-16B802408355Q34336181-E56C70D0-7C47-4569-856E-F2C5061FF3CAQ34398784-873EBC72-ABE3-4C68-A855-829C377D2D9BQ34671155-521288BA-C924-4651-9B33-9B8FB71ED53EQ35055136-CFDB4A4D-1CCF-46B6-B69B-BE0EC2EBED2CQ35088520-D41B9586-67F6-4A6C-96E4-8F495D0F3DEDQ35221400-83F4DBCA-DB8B-4E2E-8C2A-66DF63F64851Q35575768-B594FCAC-10A3-44FC-B90C-B6652B255FF2Q35743645-0252E9CE-20C7-48C5-9C5F-2174548A82C5Q35781098-F772E4D0-E90A-49E9-8271-490F62D4549DQ37026196-1C071BE9-BC27-4983-B1D5-5FA547DB30D8Q37193673-B1BEDADA-4E61-4012-BAC2-3689069B9303Q37331128-31BDA60E-CEB7-4323-BD56-9D4D134B2DE1Q38061853-BEE0086C-D002-4366-9D04-24C858FBC460Q38268577-66B594F4-95EF-4842-8BE5-926EB462A60CQ39107533-F6BBE8A0-DB69-4E37-A6CF-C2A64FCA59A1Q39127413-9B82819A-F6F4-4B76-917D-4DDA8E827C81Q39184189-CF61881D-F944-4293-BED1-57C712FB72D5Q40026114-75C59A4B-29E4-4C00-98FF-FC5067637B3AQ40140158-744FF093-B186-4DEF-B9B7-99B92E375C2CQ40462668-315EE62A-B79B-4DD6-80E2-C9BE8E21061AQ42331648-C0BAFF9A-BA46-4AD1-8964-0D9822E42589Q45729158-4277EF19-7F71-44EA-A8AE-E132A925273AQ46573671-1BCF25B3-FF54-4274-B6D0-D3B22AE6F388Q47564766-429A534D-C0A7-4C74-AB18-B98EAED1A7BEQ51249836-6E4BDD53-B53C-41A2-B965-E8E24B34069BQ51313552-04FCE61E-0193-4BEA-B54F-BC3BF6789BA4Q51313679-2A054262-B2AF-4800-8862-E57B6DDE2B38Q51338515-B9A206D3-705E-47B8-91AD-6414CB48A36EQ51348211-9C347971-93D0-408F-944A-33FDA8378984Q52577415-C0A5B84C-A7B9-4DB0-B5E7-28D0E211795AQ55422940-5760858F-81D6-4BEE-80C1-5C0DF30D986B
P2860
Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@ast
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@en
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@nl
type
label
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@ast
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@en
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@nl
prefLabel
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@ast
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@en
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@nl
P2093
P2860
P50
P356
P1476
Identifying dysglycemic states ...... merging use of hemoglobin A1c.
@en
P2093
Alka Kanaya
Bret H Goodpaster
Karen C Johnson
Kasia J Lipska
Nathalie De Rekeneire
Peter H Van Ness
Silvio E Inzucchi
Thomas M Gill
P2860
P304
P356
10.1210/JC.2010-1171
P407
P577
2010-09-22T00:00:00Z